Data from another independent cohort of colorectal cancer patients of all TNM stages61 show a significant reduction in FAM46C/Plk4 ratio in primary tumor (T) vs. NM (Fig. 6e), and further depletion of FAM46C with clinical stage progression, as apparent in our own initial patient cohort (Fig. 6f). Here, TENT5C is linked to colorectal cancer.